Stockreport

Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and Investigational Programs for Neurodegenerative Diseases

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF New data underscore benefits of SPINRAZA® (nusinersen) across broad spinal muscular atrophy (SMA) populations and include longer-term efficac [Read more]